Boston Children’s Hospital is the 18th university or research institute to receive academic bridge funding from Deerfield Management.
Healthcare-focused investment firm Deerfield has unveiled a $65m venture fund called Blackfan Circle Innovations to back nascent biomedical research from Boston Children’s Hospital.
Boston Children’s is the primary paediatric teaching hospital for Harvard University’s Medical School.
The colloboration is Deerfield’s first with a paediatric hospital and brings its total number of academic and research institute partners to 18.
Deerfield managing partner James Flynn offered an in-depth look at the firm’s partnerships in the October edition of GUV magazine.
Blackfan Circle Innovations will back discovery-stage projects in therapeutic areas including rare diseases, aiming to sustain research toward the clinic.
A joint committee of Deerfield and Boston Children’s scientific leadership will screen potential investments.
The fund has an option to license portfolio assets and Deerfield could provide follow-on funding for some clinical-stage programs.
James Flynn said: “Boston Children’s world-class discovery platforms, including in genetics and rare diseases, and experience with highly diverse patient populations, epitomise the focus and vision we share.
“Collectively, with our development expertise, we will advance novel treatments with the goal to improve and save lives.”
